Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H13NO4 |
Molecular Weight | 211.2145 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O
InChI
InChIKey=CJCSPKMFHVPWAR-SNVBAGLBSA-N
InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m1/s1
DescriptionSources: https://www.drugs.com/pro/methyldopa.html
Sources: https://www.drugs.com/pro/methyldopa.html
D-Methyldopa is an inactive isomer of methyldopa. It is known, that only L-isomer has the ability to inhibit dopa decarboxylase and possesses the antihypertensive activity in man. Moreover, about twice the dose of the racemate (DL-form of methyldopa) is required for the equal antihypertensive effect.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
NCT00976235
Created by
admin on Sat Dec 16 08:04:59 GMT 2023 , Edited by admin on Sat Dec 16 08:04:59 GMT 2023
|
PRIMARY | |||
|
DTXSID50859484
Created by
admin on Sat Dec 16 08:04:59 GMT 2023 , Edited by admin on Sat Dec 16 08:04:59 GMT 2023
|
PRIMARY | |||
|
8K91SZC8W9
Created by
admin on Sat Dec 16 08:04:59 GMT 2023 , Edited by admin on Sat Dec 16 08:04:59 GMT 2023
|
PRIMARY | |||
|
2799-15-7
Created by
admin on Sat Dec 16 08:04:59 GMT 2023 , Edited by admin on Sat Dec 16 08:04:59 GMT 2023
|
PRIMARY | |||
|
721860
Created by
admin on Sat Dec 16 08:04:59 GMT 2023 , Edited by admin on Sat Dec 16 08:04:59 GMT 2023
|
PRIMARY |
ACTIVE MOIETY